NCT02223169View on ClinicalTrials.gov

Human Intervention Study of Egg Protein Derivative on Cardiovascular Risk

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions

Hypertension

Interventions

DIETARY_SUPPLEMENT

Egg albumin-derived peptide

Double-blind intervention study cross-over design with one sachet containing 3g Egg albumin-derived peptide (Tensio-control) or placebo (maltodextrin) in Phase one followed by cross-over in Phase 2.

Trial Locations (2)

Unknown

School of Food and Nutritional Sciences, UCC, Cork

University College Cork, Cork

All Listed Sponsors

lead

University College Cork

OTHER

NCT02223169 - Human Intervention Study of Egg Protein Derivative on Cardiovascular Risk | Biotech Hunter | Biotech Hunter